Given the chronic nature of retinal diseases and the frequent need for several courses of anti-VEGF treatment to achieve noticeable visual improvements, dissatisfaction with initial outcomes may be a result of unrealistic expectations. This evidence concerns the gene VEGFA and Abnormal retinal morphology.